HYpofractionateD RadioAblative (HYDRA) Treatment of Advanced Laryngeal Cancer

NCT02464137 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

15

Enrollment

OTHER

Sponsor class

Stopped unexpected toxicities

Conditions

Squamous Cell Carcinoma of the Larynx

Interventions

RADIATION: radiation

Sponsor

University of Texas Southwestern Medical Center